{"downloaded": true, "htmlmade": false, "full": {"id": "32508330", "source": "MED", "pmid": "32508330", "pmcid": "PMC7458533", "fullTextIdList": {"fullTextId": "PMC7458533"}, "doi": "10.3233/jpd-201965", "title": "Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk.", "authorString": "Kayed R, Dettmer U, Lesn\u00e9 SE.", "authorList": {"author": [{"fullName": "Kayed R", "firstName": "Rakez", "lastName": "Kayed", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Departments of Neurology & Neuroscience & Cell Biology & Anatomy, University of Texas Medical Branch Galveston, Galveston, TX, USA."}, {"affiliation": "George and Cynthia Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch Galveston, Galveston, TX, USA."}]}}, {"fullName": "Dettmer U", "firstName": "Ulf", "lastName": "Dettmer", "initials": "U", "authorId": {"@type": "ORCID", "#text": "0000-0001-6676-0107"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Neurology, Harvard Medical School, Boston, MA, USA."}, {"affiliation": "Ann Romney Center for Neurologic Diseases, Harvard Medical School, Boston, MA, USA."}]}}, {"fullName": "Lesn\u00e9 SE", "firstName": "Sylvain E", "lastName": "Lesn\u00e9", "initials": "SE", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA."}, {"affiliation": "Institute of Translational Neuroscience, University of Minnesota, Minneapolis, MN, USA."}]}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0001-6676-0107"}}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "3", "volume": "10", "journalIssueId": "2989405", "dateOfPublication": "2020", "monthOfPublication": "0", "yearOfPublication": "2020", "printPublicationDate": "2020-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2020", "pageInfo": "791-818", "abstractText": "There is growing recognition in the field of neurodegenerative diseases that mixed proteinopathies are occurring at greater frequency than originally thought. This is particularly true for three amyloid proteins defining most of these neurological disorders, amyloid-beta (A\u03b2), tau, and alpha-synuclein (\u03b1Syn). The co-existence and often co-localization of aggregated forms of these proteins has led to the emergence of concepts positing molecular interactions and cross-seeding between A\u03b2, tau, and \u03b1Syn aggregates. Amongst this trio, \u03b1Syn has received particular attention in this context during recent years due to its ability to modulate A\u03b2 and tau aggregation in vivo, to interact at a molecular level with A\u03b2 and tau in vivo and to cross-seed tau in mice. Here we provide a comprehensive, critical, and accessible review about the expression, role and nature of endogenous soluble \u03b1Syn oligomers because of recent developments in the understanding of \u03b1Syn multimerization, misfolding, aggregation, cross-talk, spreading and cross-seeding in neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, Alzheimer's disease, and Huntington's disease. We will also discuss our current understanding about the relative toxicity of endogenous \u03b1Syn oligomers in vivo and in vitro, and introduce potential opportunities to counter their deleterious effects.", "affiliation": "Departments of Neurology & Neuroscience & Cell Biology & Anatomy, University of Texas Medical Branch Galveston, Galveston, TX, USA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"grantId": "R01 AG054025", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}, {"grantId": "R21 AG065693", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}, {"grantId": "R01 NS094557", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}, {"grantId": "R56 NS113549", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}, {"grantId": "RF1 AG044342", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}, {"grantId": "RF1 AG062135", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}, {"grantId": "RF1 AG055771", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}, {"grantId": "R01 NS092918", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}, {"grantId": "R01 NS099328", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}]}, "keywordList": {"keyword": ["Aggregation", "Neurodegenerative disease", "Oligomer", "Tau", "\u03b1-synuclein", "Cross-talk", "Amyloid-\u03b2", "Multimer", "Cross-seeding"]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-201965"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7458533"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC7458533?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "6", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "nct"}, "dateOfCreation": "2020-06-09", "firstIndexDate": "2020-06-08", "fullTextReceivedDate": "2020-09-13", "dateOfRevision": "2021-04-14", "firstPublicationDate": "2020-01-01"}, "htmllinks": "https://europepmc.org/articles/PMC7458533", "abstract": "There is growing recognition in the field of neurodegenerative diseases that mixed proteinopathies are occurring at greater frequency than originally thought. This is particularly true for three amyloid proteins defining most of these neurological disorders, amyloid-beta (A\u03b2), tau, and alpha-synuclein (\u03b1Syn). The co-existence and often co-localization of aggregated forms of these proteins has led to the emergence of concepts positing molecular interactions and cross-seeding between A\u03b2, tau, and \u03b1Syn aggregates. Amongst this trio, \u03b1Syn has received particular attention in this context during recent years due to its ability to modulate A\u03b2 and tau aggregation in vivo, to interact at a molecular level with A\u03b2 and tau in vivo and to cross-seed tau in mice. Here we provide a comprehensive, critical, and accessible review about the expression, role and nature of endogenous soluble \u03b1Syn oligomers because of recent developments in the understanding of \u03b1Syn multimerization, misfolding, aggregation, cross-talk, spreading and cross-seeding in neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, Alzheimer's disease, and Huntington's disease. We will also discuss our current understanding about the relative toxicity of endogenous \u03b1Syn oligomers in vivo and in vitro, and introduce potential opportunities to counter their deleterious effects.", "Keywords": ["Aggregation", "Neurodegenerative disease", "Oligomer", "Tau", "\u03b1-synuclein", "Cross-talk", "Amyloid-\u03b2", "Multimer", "Cross-seeding"], "pdflinks": "https://europepmc.org/articles/PMC7458533?pdf=render", "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Kayed R", "Dettmer U", "Lesn\u00e9 SE"], "title": "Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk."}